Literature DB >> 23764643

Future of phylogeny in HIV prevention.

Bluma G Brenner1, Mark A Wainberg.   

Abstract

The success of the HIV Prevention Trials Network 052 trial has led to revisions in HIV-1 treatment guidelines. Antiretroviral therapy may reduce the risk of HIV-1 transmissions at the population level. The design of successful treatment as prevention interventions will be predicated on a comprehensive understanding of the spatial, temporal, and biological dynamics of heterosexual men who have sex with men and intravenous drug user epidemics. Viral phylogenetics can capture the underlying structure of transmission networks based on the genetic interrelatedness of viral sequences and cluster networks that could not be otherwise identified. This article describes the phylogenetic expansion of the Montreal men who have sex with men epidemic over the last decade. High rates of coclustering of primary infections are associated with 1 infection leading to 13 onward transmissions. Phylogeny substantiates the role of primary and recent stage infection in transmission dynamics, underlying the importance of timely diagnosis and immediate antiretroviral therapy initiation to avert transmission cascades.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23764643      PMCID: PMC3689150          DOI: 10.1097/QAI.0b013e3182986f96

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  102 in total

1.  Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity.

Authors:  Matthew M Cousins; San-San Ou; Maria J Wawer; Supriya Munshaw; David Swan; Craig A Magaret; Caroline E Mullis; David Serwadda; Stephen F Porcella; Ronald H Gray; Thomas C Quinn; Deborah Donnell; Susan H Eshleman; Andrew D Redd
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.

Authors:  Delivette Castor; Andrea Low; Teresa Evering; Sharon Karmon; Brandi Davis; Amir Figueroa; Melissa LaMar; Donald Garmon; Saurabh Mehandru; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

3.  Investigation of HIV-1 transmission events by phylogenetic methods: requirement for scientific rigour.

Authors:  Stéphane Hué; Jonathan P Clewley; Patricia A Cane; Deenan Pillay
Journal:  AIDS       Date:  2005-03-04       Impact factor: 4.177

4.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

5.  Designing a genome-based HIV incidence assay with high sensitivity and specificity.

Authors:  Sung Yong Park; Tanzy M T Love; Jeremy Nelson; Sally W Thurston; Alan S Perelson; Ha Youn Lee
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

6.  Persistently high prevalence and unrecognized HIV infection among men who have sex with men in Baltimore: the BESURE study.

Authors:  Danielle German; Frangiscos Sifakis; Cathy Maulsby; Vivian L Towe; Colin P Flynn; Carl A Latkin; David D Celentano; Heather Hauck; David R Holtgrave
Journal:  J Acquir Immune Defic Syndr       Date:  2011-05-01       Impact factor: 3.731

7.  Understanding disparities in HIV infection between black and white MSM in the United States.

Authors:  Alexandra M Oster; Ryan E Wiegand; Catlainn Sionean; Isa J Miles; Peter E Thomas; Lehida Melendez-Morales; Binh C Le; Gregorio A Millett
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

8.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

9.  HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation.

Authors:  Wim Delva; David P Wilson; Laith Abu-Raddad; Marelize Gorgens; David Wilson; Timothy B Hallett; Alex Welte
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

10.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more
  20 in total

1.  Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.

Authors:  Vlad Novitsky; Melissa Zahralban-Steele; Mary Fran McLane; Sikhulile Moyo; Erik van Widenfelt; Simani Gaseitsiwe; Joseph Makhema; M Essex
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

Review 2.  Factors Driving the HIV Epidemic in Southern Africa.

Authors:  Lyle R McKinnon; Quarraisha Abdool Karim
Journal:  Curr HIV/AIDS Rep       Date:  2016-06       Impact factor: 5.071

3.  Molecular Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals in a Network-Based Intervention (Transmission Reduction Intervention Project): Phylogenetics Identify HIV-1-Infected Individuals With Social Links.

Authors:  Evangelia-Georgia Kostaki; Georgios K Nikolopoulos; Eirini Pavlitina; Leslie Williams; Gkikas Magiorkinis; John Schneider; Britt Skaathun; Ethan Morgan; Mina Psichogiou; Georgios L Daikos; Vana Sypsa; Pavlo Smyrnov; Ania Korobchuk; Meni Malliori; Angelos Hatzakis; Samuel R Friedman; Dimitrios Paraskevis
Journal:  J Infect Dis       Date:  2018-07-24       Impact factor: 5.226

Review 4.  Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?

Authors:  Ann M Dennis; Joshua T Herbeck; Andrew L Brown; Paul Kellam; Tulio de Oliveira; Deenan Pillay; Christophe Fraser; Myron S Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

5.  Assessment of Overlap of Phylogenetic Transmission Clusters and Communities in Simple Sexual Contact Networks: Applications to HIV-1.

Authors:  Luc Villandre; David A Stephens; Aurelie Labbe; Huldrych F Günthard; Roger Kouyos; Tanja Stadler
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 6.  Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings.

Authors:  Bluma G Brenner; Ruxandra-Ilinca Ibanescu; Isabelle Hardy; Michel Roger
Journal:  Viruses       Date:  2017-12-28       Impact factor: 5.048

Review 7.  Clinical and public health implications of acute and early HIV detection and treatment: a scoping review.

Authors:  Sarah E Rutstein; Jintanat Ananworanich; Sarah Fidler; Cheryl Johnson; Eduard J Sanders; Omar Sued; Asier Saez-Cirion; Christopher D Pilcher; Christophe Fraser; Myron S Cohen; Marco Vitoria; Meg Doherty; Joseph D Tucker
Journal:  J Int AIDS Soc       Date:  2017-06-28       Impact factor: 5.396

8.  Sources of HIV infection among men having sex with men and implications for prevention.

Authors:  Oliver Ratmann; Ard van Sighem; Daniela Bezemer; Alexandra Gavryushkina; Suzanne Jurriaans; Annemarie Wensing; Frank de Wolf; Peter Reiss; Christophe Fraser
Journal:  Sci Transl Med       Date:  2016-01-06       Impact factor: 17.956

9.  Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.

Authors:  Jason Grebely; Viviane Dias Lima; Brandon D L Marshall; M-J Milloy; Kora DeBeck; Julio Montaner; Annick Simo; Mel Krajden; Gregory J Dore; Thomas Kerr; Evan Wood
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

10.  Short-Term Dynamic and Local Epidemiological Trends in the South American HIV-1B Epidemic.

Authors:  Dennis Maletich Junqueira; Rubia Marília de Medeiros; Tiago Gräf; Sabrina Esteves de Matos Almeida
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.